Trending...
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
Pandemic Exacerbates Scarcity of Substance Abuse Inpatient Treatment Facilities Nationwide
KANSAS CITY, Mo. - nvtip -- COVID-19 is fueling an explosion in drug overdose deaths nationally. Drug overdose deaths soared nationally to the highest number ever recorded.
It's been "like pouring gasoline on a fire," says Lane Slaten founder and CEO of CWMN LLC, national developer of behavioral health inpatient facilities.
The CDC says the latest numbers suggest an acceleration of overdose deaths during the pandemic. Nationwide, they rose 26% in the 12 months ending in May. Covid circumstances have more people seeking addiction and mental health help, but treatment centers are in short supply, which is exacerbating opioid overdose deaths. "The problem is there is an enormous shortage of substance abuse inpatient treatment facilities nationwide," said Slaten.
In this covid climate, there has been a flood of private equity (PE) investment paying close attention, and private-equity firms are starting to pile into the new business opportunity of addiction treatment facilities, drawn by soaring demand, expanded insurance coverage, and the chance to consolidate a highly fragmented market. The firms are acquiring or expanding clinics that provide everything from detox and residential care to outpatient and methadone treatment. In some cases, private-equity firms have approached not-for-profit outfits in an attempt to buy and convert them to for-profit entities, say treatment-center executives.
More on nvtip.com
Mr. Slaten is positioning himself to become the "driving force" in growing turnkey-ready inpatient facilities from coast-to-coast. "I'm committed to developing up to three large residential care facilities a year to help dampen the coming inferno post covid," Slaten explained. Currently he is finalizing the development of his second inpatient facility in the Kansas City Metropolitan Area. It's a 86,000 SF turnkey-ready 120 bed capacity residential care facility that was recently listed on LoopNet.com for $7,900,000. More property information can be found at www.InpatientFacility.com or take a quick video tour.
For More Info Contact:
Lane Slaten
CWMN, LLC
Founder & CEO
913-444-9911
Lane's LinkedIn: @lane-slaten
It's been "like pouring gasoline on a fire," says Lane Slaten founder and CEO of CWMN LLC, national developer of behavioral health inpatient facilities.
The CDC says the latest numbers suggest an acceleration of overdose deaths during the pandemic. Nationwide, they rose 26% in the 12 months ending in May. Covid circumstances have more people seeking addiction and mental health help, but treatment centers are in short supply, which is exacerbating opioid overdose deaths. "The problem is there is an enormous shortage of substance abuse inpatient treatment facilities nationwide," said Slaten.
In this covid climate, there has been a flood of private equity (PE) investment paying close attention, and private-equity firms are starting to pile into the new business opportunity of addiction treatment facilities, drawn by soaring demand, expanded insurance coverage, and the chance to consolidate a highly fragmented market. The firms are acquiring or expanding clinics that provide everything from detox and residential care to outpatient and methadone treatment. In some cases, private-equity firms have approached not-for-profit outfits in an attempt to buy and convert them to for-profit entities, say treatment-center executives.
More on nvtip.com
- Verb™ Presents Features Vanguard Personalized Indexing: Utilizing Advanced Tax-Loss Harvesting Technology
- Luckygirl Bodywork Opens in Silverado Park Place Area
- UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
Mr. Slaten is positioning himself to become the "driving force" in growing turnkey-ready inpatient facilities from coast-to-coast. "I'm committed to developing up to three large residential care facilities a year to help dampen the coming inferno post covid," Slaten explained. Currently he is finalizing the development of his second inpatient facility in the Kansas City Metropolitan Area. It's a 86,000 SF turnkey-ready 120 bed capacity residential care facility that was recently listed on LoopNet.com for $7,900,000. More property information can be found at www.InpatientFacility.com or take a quick video tour.
For More Info Contact:
Lane Slaten
CWMN, LLC
Founder & CEO
913-444-9911
Lane's LinkedIn: @lane-slaten
Source: CWMN, LLC
Filed Under: Financial
0 Comments
Latest on nvtip.com
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
- New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough




